[PDF][PDF] COVID-19 in Saudi Arabia: the national health response

A Khan, Y Alsofayan, A Alahmari, J Alowais… - Eastern Mediterranean …, 2021 - apps.who.int
Background: With the spread of coronavirus disease 2019 (COVID-19), most countries rushed
to take early measures to control this disease. Aims: This paper describes and evaluates …

[HTML][HTML] Epidemiological and clinical features of COVID-19 patients in Saudi Arabia

AA Alahmari, AA Khan, A Elganainy… - Journal of Infection and …, 2021 - Elsevier
Background The aim of this study is to describe the clinical and demographic characteristics
of COVID-19 patients, and the risk factors associated with death in Saudi Arabia to serve as …

The role of digital technology in responding to COVID-19 pandemic: Saudi Arabia's experience

A Khan, A Alahmari, Y Almuzaini, N Alturki… - … and Healthcare Policy, 2021 - Taylor & Francis
Introduction The novel coronavirus (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), a single-chain ribonucleic acid (RNA) virus. As of March …

[HTML][HTML] Hajj 2021: Role of mitigation measures for health security

AA Alahmari, AA Khan, FA Alamri, YS Almuzaini… - Journal of Infection and …, 2022 - Elsevier
Purpose After the impressive results of the 2020 Hajj management, Saudi authorities
decided to expand the quota to 60,000 pilgrims in 2021, which resulted in a convenient and …

[HTML][HTML] Healthcare policies, precautionary measures and outcomes of mass gathering events in the era of COVID-19 pandemic: Expedited review

AA Alahmari, AA Khan, FA Alamri, YS Almuzaini… - Journal of infection and …, 2024 - Elsevier
With the onset of the COVID-19 pandemic in early 2020, several countries suspended or
restricted mass gathering (MG) events to mitigate the risk of superspreading events. Prohibiting …

[HTML][HTML] Thromboembolic events associated with bevacizumab plus chemotherapy for patients with colorectal cancer: a meta-analysis of randomized controlled trials

AK Alahmari, ZS Almalki, AK Alahmari… - American Health & Drug …, 2016 - ncbi.nlm.nih.gov
Background Bevacizumab is a recombinant, humanized monoclonal antibody that hinders
the proliferation of new blood vessels required for malignant progression. The drug is …

[HTML][HTML] Post-acute COVID-19 condition in Saudi Arabia: A national representative study

…, M Abdulrahim, A Almogbil, A Alahmari - Journal of Infection and …, 2022 - Elsevier
Background Many survivors of COVID-19 have developed symptoms and diseases similar
to those observed after severe acute respiratory syndrome (SARS). Therefore, this study …

[HTML][HTML] Potential cross-reactive immunity to COVID-19 infection in individuals with laboratory-confirmed MERS-CoV infection: a national retrospective cohort study …

AA Khan, AA Alahmari, Y Almuzaini, F Alamri… - Frontiers in …, 2021 - frontiersin.org
Background A growing number of experiments have suggested potential cross-reactive
immunity between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and …

Risk communication effectiveness during COVID-19 pandemic among general population in Saudi Arabia

…, A Aburas, Y Yassin, F Alamri, A Alahmari… - … and healthcare policy, 2021 - Taylor & Francis
Purpose The novel coronavirus (COVID-19), declared a pandemic by WHO in March 2020,
is an unprecedented occurrence in our recent history. Effective risk communication by health …

[HTML][HTML] Municipal wastewater viral pollution in Saudi Arabia: effect of hot climate on COVID-19 disease spreading

…, H Sonbol, A Khan, Y Alsofayan, A Alahmari - … Science and Pollution …, 2023 - Springer
The viral RNA of SARS-Coronavirus-2 is known to be contaminating municipal wastewater.
We aimed to assess if COVID-19 disease is spreading through wastewater. We studied the …